|
|
Lifespan's A - Z Health Information Library |
|
Macroglobulinemia of WaldenstromDefinitionMacroglobulinemia of Waldenstrom is a cancer of the B lymphocytes (a type of white blood cell). Such cancer is called lymphoplasmacytic lymphoma. It is associated with the overproduction of proteins called IgM antibodies. Alternative NamesWaldenstrom's macroglobulinemia; Macroglobulinemia - primary;
Lymphoplasmacytic lymphoma CausesThe cause of the overproduction of the IgM antibody is unknown. Overproduction of IgM causes the blood to become too thick. This is called hyperviscosity. It makes it harder for blood to flow through small blood vessels. About 1,500 people in the United States are diagnosed with Waldenstrom's macroglobulinemia every year. Most people with this condition are over age 65, however, it may occur in younger people. Symptoms
Additional symptoms that may be associated with this disease: Exams and TestsA physical examination may reveal a swollen spleen, liver, and lymph nodes. An eye exam may show enlarged veins in the retina or retinal bleeding (hemorrhages). A CBC shows a low number of red bloods and platelets. A blood chemistry shows evidence of kidney disease. A serum viscosity test can tell if the blood has become thick. Symptoms usually occur when the blood is four times thicker than normal. A test called serum protein electrophoresis shows an increased amount of the IgM antibody. Levels seen in Waldenstrom's macroglobulinemia are generally greater than 3 g/dL. Bone lesions are very rare. If they are present, a bone marrow examination will show cells that resemble both lymphocytes and plasma cells. Additional tests that may be done:
TreatmentPlasmapheresis (plasma exchange) removes unwanted substances from the blood. In macroglobulinemia, it removes or reduces the high level of IgM, and is used to quickly control the symptoms caused by blood thickening. Drug therapy may include steroids, Leukeran, Alkeran, Cytoxan, fludarabine, or rituximab. Patients who have a low number of red or white blood cells or platelets may need transfusions or antibiotics. Outlook (Prognosis)The average survival is about 5 years. In some people, the disorder may produce few symptoms and progress slowly. Possible Complications
When to Contact a Medical ProfessionalCall your health care provider if symptoms of this disorder develop. ReferencesFerri FF. Ferri’s Clinical Advisor: Instant Diagnosis and Treatment. 8th ed. St. Louis, Mo: Mosby; 2006:909. Goldman L, Ausiello D. Cecil Textbook of Medicine. 22nd ed. Philadelphia, Pa: WB Saunders; 200:1068, 1992.
Review Date:
9/20/2006 Reviewed By: Corey Cutler, MD, MPH, FRCP(C), Assistant Professor of Medicine, Harvard Medical School; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Review provided by VeriMed Healthcare Network. The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-
A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited. |
|
|
|